BRIEF-GlaxoSmithKline CEO says any ViiV IPO likely to be 2016 event

Feb 4 (Reuters) - GlaxoSmithKline Plc CEO Andrew Witty tells reporters: * CEO says any ViiV IPO likely to be 2016 event * CEO says globally scaled businesses post-Novartis deal will have more options...

from Reuters: Mergers News http://ift.tt/1Kc3HZy